BB, Now that we have NCE and stock options can be vested immediately in event of a change of control, Pfizer may acquire Amarin right after the REDUCED-IT results. This is because Pfizer will not repeat the Warner Lambert mistake twice; they will acquire earlier rather than later. Also having sued FDA twice the Amarin management would most likely not deal with FDA again. All that needs to fall in place now is the interim peek at the data. We are looking at June 2016 latest...